DR. OLABUNMI AGBOOLA

M.D.Real-Time Hydrated
Practice Location: WASHINGTON, DC 20003
NPI Number: 1861719023
LIFETIME INDUSTRY VALUE
$11,731
2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AGBOOLA is a verified Allergy & Immunology practitioner based in WASHINGTON, DC.

Between 2021 and 2025, Dr. AGBOOLA had an overall industry promotional and research financial footprint of $11,731 as recorded in the federal CMS Open Payments database.

  • $11,731 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
  • $0 was allocated to sponsored clinical trials and medical research activities.

Dr. AGBOOLA's primary funding source is GENZYME CORPORATION, which accounts for $4,485 (representing 38.2% of overall industry footprint).

Data coverage: 2021 – 2025  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments
Research Funding
$3,094$1,547$0$2,1582021$1,9052022$2,3172023$2,2572024$3,0942025

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GENZYME CORPORATION
Rank 1
$4,485
38.2%
ASTRAZENECA PHARMACEUTICALS
Rank 2
$2,498
21.3%
REGENERON HEALTHCARE SOLUTIONS
Rank 3
$643
5.5%

General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.

PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Audit Trigger

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:
2025
2025
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.